Form 13-F position report

INDIVIOR PHARMACEUTICALS INC

Reported by Westchester Capital Management LLC

INDVZZZZ CUSIP 45579U109 Manager CIK 0001512805

First reported at 775,856 shares this quarter.

New
% of reported 13F value 1.26% This manager · Q3 2026
Shares 775,856 Quarter-end amount reported
Reported value $27,814,437 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 27814437

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for INDIVIOR PHARMACEUTICALS INC held by Westchester Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 775,856 +775,856 (0.0%) 1.26% $27,814,437 2026-11-12

Who else reported the position

390 managers reported INDIVIOR PHARMACEUTICALS INC for Q3 2026.

Managers reporting INDIVIOR PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 18,634,083 -75,349 < 0.01% $668,031,877 3 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 6,986,599 -585,688 0.01% $250,469,574 3 qtrs
MILLENNIUM MANAGEMENT LLC Added 6,282,351 +4,183,406 0.07% $225,222,283 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 5,293,797 -201,689 < 0.01% $189,782,622 3 qtrs
STATE STREET CORPORATION Added 5,037,536 +45,465 < 0.01% $180,595,666 3 qtrs
Madison Avenue Partners LP Added 4,851,975 +1,977,607 6.91% $173,943,304 4 qtrs
FULLER & THALER ASSET MANAGEMENT INC Reduced 4,139,533 -476,283 0.44% $148,402,248 3 qtrs
WESTFIELD CAPITAL MANAGEMENT CO LP Added 3,895,136 +2,853,945 0.46% $139,640,626 2 qtrs
Rubric Capital Management LP New 3,862,989 +3,862,989 1.3% $138,488,156 3 qtrs
Two Seas Capital LP Added 3,671,072 +191,579 1.52% $131,607,931 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 12, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
74,937
Shared
700,919
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.